Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1996 1
2001 2
2002 31
2003 59
2004 57
2005 87
2006 104
2007 146
2008 183
2009 227
2010 275
2011 316
2012 416
2013 500
2014 617
2015 698
2016 803
2017 902
2018 1080
2019 1258
2020 1494
2021 1780
2022 2098
2023 2167
2024 2456
2025 3004
2026 440

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,885 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Medical Management and Revascularization for Asymptomatic Carotid Stenosis.
Brott TG, Howard G, Lal BK, Voeks JH, Turan TN, Roubin GS, Lazar RM, Brown RD Jr, Huston J 3rd, Edwards LJ, Jones M, Clark WM, Chamorro Á, Llull L, Mena-Hurtado C, Heck D, Marshall RS, Howard VJ, Moore WS, Barrett KM, Demaerschalk BM, Sangha N, Aronow H, Foster M, Sternbergh WC 3rd, Shawl F, Lanzino G, Rapp J, Tran HS, Ecker R, Mackey A, Ali V, Given C 2nd, Teal P, Kashyap VS, Mukherjee D, Harrigan M, Silverman S, Koopmann M, Wadley VG, Zhang Y, Rhodes JD, Chaturvedi S, Meschia JF; CREST-2 Investigators. Brott TG, et al. Among authors: zhang y. N Engl J Med. 2026 Jan 15;394(3):219-231. doi: 10.1056/NEJMoa2508800. Epub 2025 Nov 21. N Engl J Med. 2026. PMID: 41269206 Clinical Trial.
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.
Huo X, Ma G, Tong X, Zhang X, Pan Y, Nguyen TN, Yuan G, Han H, Chen W, Wei M, Zhang J, Zhou Z, Yao X, Wang G, Song W, Cai X, Nan G, Li D, Wang AY, Ling W, Cai C, Wen C, Wang E, Zhang L, Jiang C, Liu Y, Liao G, Chen X, Li T, Liu S, Li J, Gao F, Ma N, Mo D, Song L, Sun X, Li X, Deng Y, Luo G, Lv M, He H, Liu A, Zhang J, Mu S, Liu L, Jing J, Nie X, Ding Z, Du W, Zhao X, Yang P, Liu L, Wang Y, Liebeskind DS, Pereira VM, Ren Z, Wang Y, Miao Z; ANGEL-ASPECT Investigators. Huo X, et al. N Engl J Med. 2023 Apr 6;388(14):1272-1283. doi: 10.1056/NEJMoa2213379. Epub 2023 Feb 10. N Engl J Med. 2023. PMID: 36762852 Clinical Trial.
Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial.
Zhou Y, Wu F, Shi Z, Cao J, Tian J, Yao W, Wei L, Li F, Cai S, Shen Y, Wang Z, Zhang H, Chen Y, Fu Y, He Z, Chang C, Jiang Y, Chen S, Yang C, Yu S, Tian H, Cheng Q, Zhao Z, Ying Y, Zhou Y, Liu S, Deng Z, Huang P, Zhang Y, Luo X, Zhao H, Gui J, Lai W, Hu G, Liu C, Su L, Liu Z, Huang J, Zhao D, Zhong N, Ran P; China N-acetylcysteine in Mild-to-moderate COPD Study Group. Zhou Y, et al. Nat Commun. 2024 Sep 30;15(1):8468. doi: 10.1038/s41467-024-51079-1. Nat Commun. 2024. PMID: 39349461 Free PMC article. Clinical Trial.
3D post-implantation co-culture of human embryo and endometrium.
Song J, Zhao R, Zhang Y, Lu M, Liu P, Li T, Li C, Yu R, Chen X, Yang H, Zhang X, Su Y, Han Y, Sun D, Zhou Q, Hou Z, Liu W, Gao X, Tao W, Zhang J, Wang J, Qin Y, Wang H, Wu K, Wu J, Chen ZJ, Zhao H. Song J, et al. Among authors: zhang y. Cell Stem Cell. 2026 Jan 8;33(1):58-72.e7. doi: 10.1016/j.stem.2025.12.002. Epub 2025 Dec 23. Cell Stem Cell. 2026. PMID: 41443195 Free article.
Image-guided volumetric bioprinting.
Robinson TM, Zhang YS, Lim KS. Robinson TM, et al. Trends Biotechnol. 2026 Feb;44(2):293-294. doi: 10.1016/j.tibtech.2025.12.015. Epub 2026 Jan 20. Trends Biotechnol. 2026. PMID: 41565538
18,885 results
You have reached the last available page of results. Please see the User Guide for more information.